DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,120
-410 (-2.64%)
At close: Feb 6, 2026
44.83%
Market Cap264.85B +27.8%
Revenue (ttm)149.47B +1.1%
Net Income39.73M
EPS2.27
Shares Out17.52M
PE Ratio6,666.89
Forward PEn/a
Dividend150.00 (0.99%)
Ex-Dividend DateDec 29, 2025
Volume138,638
Average Volume136,084
Open15,050
Previous Close15,530
Day's Range14,600 - 15,390
52-Week Range9,960 - 24,900
Beta-0.30
RSI35.91
Earnings DateFeb 6, 2026

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 067080
Full Company Profile

Financial Performance

Financial Statements